Bridgebio Pharma Stock Price History
| BBIO Stock | USD 34.90 3.34 10.58% |
Below is the normalized historical share price chart for BridgeBio Pharma extending back to June 27, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BridgeBio Pharma stands at 34.90, as last reported on the 17th of February 2025, with the highest price reaching 34.99 and the lowest price hitting 31.56 during the day.
If you're considering investing in BridgeBio Stock, it is important to understand the factors that can impact its price. BridgeBio Pharma appears to be very steady, given 3 months investment horizon. BridgeBio Pharma secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19 % return per unit of risk over the last 3 months. By analyzing BridgeBio Pharma's technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please makes use of BridgeBio Pharma's Risk Adjusted Performance of 0.0856, downside deviation of 3.16, and Mean Deviation of 2.93 to double-check if our risk estimates are consistent with your expectations.
At this time, BridgeBio Pharma's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 17th of February 2025, Other Stockholder Equity is likely to grow to about 1.5 B, though Total Stockholder Equity is likely to grow to (1.2 B). . At this time, BridgeBio Pharma's Price To Sales Ratio is very stable compared to the past year. As of the 17th of February 2025, Price Sales Ratio is likely to grow to 667.57, while Price Earnings Ratio is likely to drop (9.66). BridgeBio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of June 2019 | 200 Day MA 27.4553 | 50 Day MA 30.9453 | Beta 1.071 |
BridgeBio |
Sharpe Ratio = 0.1872
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BBIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.31 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.81 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average BridgeBio Pharma is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BridgeBio Pharma by adding it to a well-diversified portfolio.
Price Book 123.6828 | Enterprise Value Ebitda (9.40) | Price Sales 30.2884 | Shares Float 131.9 M | Wall Street Target Price 49.56 |
BridgeBio Pharma Stock Price History Chart
There are several ways to analyze BridgeBio Stock price data. The simplest method is using a basic BridgeBio candlestick price chart, which shows BridgeBio Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 24, 2025 | 37.59 |
| Lowest Price | November 19, 2024 | 22.54 |
BridgeBio Pharma February 17, 2025 Stock Price Synopsis
Various analyses of BridgeBio Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BridgeBio Stock. It can be used to describe the percentage change in the price of BridgeBio Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BridgeBio Stock.| BridgeBio Pharma Price Rate Of Daily Change | 1.11 | |
| BridgeBio Pharma Price Daily Balance Of Power | 0.97 | |
| BridgeBio Pharma Price Action Indicator | 3.29 |
BridgeBio Pharma February 17, 2025 Stock Price Analysis
BridgeBio Stock Price History Data
The price series of BridgeBio Pharma for the period between Tue, Nov 19, 2024 and Mon, Feb 17, 2025 has a statistical range of 15.24 with a coefficient of variation of 13.96. The prices are distributed with arithmetic mean of 29.5. The median price for the last 90 days is 28.39.| Open | High | Low | Close | Volume | ||
02/17/2025 | 31.56 | 34.99 | 31.56 | 34.90 | ||
02/17/2025 | 31.56 | 34.99 | 31.56 | 34.90 | ||
| 02/14/2025 | 31.63 | 34.99 | 31.63 | 34.90 | 3,373,224 | |
| 02/13/2025 | 32.29 | 32.64 | 31.22 | 31.56 | 1,726,224 | |
| 02/12/2025 | 30.50 | 32.01 | 30.50 | 31.95 | 1,285,309 | |
| 02/11/2025 | 31.56 | 32.11 | 31.02 | 31.12 | 1,645,132 | |
| 02/10/2025 | 31.92 | 32.99 | 31.68 | 31.76 | 1,681,683 | |
| 02/07/2025 | 32.55 | 32.85 | 31.76 | 31.85 | 1,527,250 | |
| 02/06/2025 | 33.83 | 33.94 | 32.59 | 32.70 | 1,742,801 | |
| 02/05/2025 | 33.14 | 34.20 | 32.66 | 33.54 | 2,375,086 | |
| 02/04/2025 | 31.18 | 33.16 | 30.84 | 32.98 | 3,109,971 | |
| 02/03/2025 | 33.73 | 33.80 | 31.00 | 31.03 | 5,112,407 | |
| 01/31/2025 | 35.83 | 36.50 | 34.00 | 34.21 | 3,032,195 | |
| 01/30/2025 | 36.42 | 36.99 | 35.42 | 35.97 | 2,246,515 | |
| 01/29/2025 | 36.23 | 36.89 | 35.80 | 36.46 | 3,128,765 | |
| 01/28/2025 | 36.71 | 36.75 | 35.74 | 36.31 | 2,763,102 | |
| 01/27/2025 | 37.50 | 37.76 | 36.25 | 36.67 | 1,568,009 | |
| 01/24/2025 | 36.88 | 37.61 | 36.40 | 37.59 | 1,730,135 | |
| 01/23/2025 | 35.54 | 37.48 | 35.31 | 37.09 | 1,403,040 | |
| 01/22/2025 | 36.13 | 36.72 | 35.31 | 35.84 | 1,827,739 | |
| 01/21/2025 | 34.01 | 36.29 | 34.01 | 36.08 | 3,739,715 | |
| 01/17/2025 | 34.50 | 34.90 | 33.76 | 33.79 | 2,877,224 | |
| 01/16/2025 | 35.19 | 35.20 | 33.73 | 34.11 | 2,841,792 | |
| 01/15/2025 | 35.75 | 36.24 | 34.56 | 35.00 | 4,127,681 | |
| 01/14/2025 | 33.73 | 36.17 | 33.55 | 35.60 | 7,638,542 | |
| 01/13/2025 | 28.98 | 34.25 | 28.10 | 33.73 | 10,113,380 | |
| 01/10/2025 | 28.63 | 29.68 | 28.45 | 29.08 | 2,053,797 | |
| 01/08/2025 | 28.66 | 29.50 | 28.25 | 29.45 | 1,662,206 | |
| 01/07/2025 | 28.39 | 28.97 | 28.17 | 28.85 | 1,461,483 | |
| 01/06/2025 | 28.11 | 28.44 | 27.86 | 28.26 | 1,330,021 | |
| 01/03/2025 | 28.16 | 28.56 | 27.79 | 28.12 | 1,281,657 | |
| 01/02/2025 | 27.79 | 29.00 | 27.53 | 28.20 | 1,396,534 | |
| 12/31/2024 | 27.50 | 27.89 | 27.32 | 27.44 | 881,653 | |
| 12/30/2024 | 27.90 | 27.99 | 27.23 | 27.32 | 1,086,779 | |
| 12/27/2024 | 28.17 | 28.82 | 27.60 | 27.99 | 1,250,890 | |
| 12/26/2024 | 28.18 | 28.84 | 27.78 | 28.39 | 1,025,591 | |
| 12/24/2024 | 27.76 | 28.59 | 27.56 | 28.53 | 939,010 | |
| 12/23/2024 | 26.75 | 27.79 | 26.55 | 27.77 | 1,475,364 | |
| 12/20/2024 | 26.04 | 26.90 | 26.02 | 26.49 | 4,196,359 | |
| 12/19/2024 | 26.08 | 26.61 | 25.34 | 26.21 | 2,465,541 | |
| 12/18/2024 | 27.88 | 28.15 | 25.51 | 25.98 | 2,746,793 | |
| 12/17/2024 | 27.43 | 27.98 | 27.17 | 27.82 | 1,526,287 | |
| 12/16/2024 | 27.69 | 28.18 | 27.42 | 27.71 | 1,869,132 | |
| 12/13/2024 | 27.68 | 28.28 | 27.00 | 27.49 | 1,482,601 | |
| 12/12/2024 | 28.73 | 29.17 | 27.45 | 27.67 | 1,851,591 | |
| 12/11/2024 | 29.31 | 29.71 | 28.94 | 28.98 | 1,251,297 | |
| 12/10/2024 | 29.66 | 29.99 | 28.61 | 29.04 | 1,556,692 | |
| 12/09/2024 | 28.64 | 29.54 | 28.36 | 29.50 | 1,600,431 | |
| 12/06/2024 | 26.96 | 29.30 | 26.55 | 28.79 | 2,922,656 | |
| 12/05/2024 | 26.86 | 27.23 | 26.36 | 26.66 | 1,155,433 | |
| 12/04/2024 | 26.42 | 27.80 | 26.30 | 27.10 | 1,653,079 | |
| 12/03/2024 | 26.42 | 27.08 | 26.32 | 26.58 | 1,777,756 | |
| 12/02/2024 | 26.86 | 27.17 | 26.15 | 26.60 | 1,347,121 | |
| 11/29/2024 | 27.84 | 28.04 | 27.08 | 27.09 | 1,120,516 | |
| 11/27/2024 | 26.53 | 28.20 | 26.25 | 27.49 | 2,491,761 | |
| 11/26/2024 | 26.93 | 27.88 | 25.52 | 26.44 | 4,317,413 | |
| 11/25/2024 | 28.81 | 30.51 | 26.86 | 27.19 | 14,615,080 | |
| 11/22/2024 | 23.13 | 23.65 | 22.47 | 23.42 | 2,088,438 | |
| 11/21/2024 | 23.04 | 23.63 | 22.82 | 23.24 | 2,069,373 | |
| 11/20/2024 | 22.42 | 23.16 | 22.05 | 23.04 | 1,395,914 | |
| 11/19/2024 | 22.27 | 22.94 | 21.72 | 22.54 | 2,148,572 |
About BridgeBio Pharma Stock history
BridgeBio Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BridgeBio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BridgeBio Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BridgeBio Pharma stock prices may prove useful in developing a viable investing in BridgeBio Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 187.2 M | 135.5 M | |
| Net Loss | -433.1 M | -454.7 M |
BridgeBio Pharma Quarterly Net Working Capital |
|
BridgeBio Pharma Stock Technical Analysis
BridgeBio Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
BridgeBio Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BridgeBio Pharma's price direction in advance. Along with the technical and fundamental analysis of BridgeBio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BridgeBio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0856 | |||
| Jensen Alpha | 0.4624 | |||
| Total Risk Alpha | 0.4573 | |||
| Sortino Ratio | 0.1464 | |||
| Treynor Ratio | 0.3122 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BridgeBio Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BridgeBio Pharma. If investors know BridgeBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BridgeBio Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.42) | Revenue Per Share | Quarterly Revenue Growth (0.33) | Return On Assets | Return On Equity |
The market value of BridgeBio Pharma is measured differently than its book value, which is the value of BridgeBio that is recorded on the company's balance sheet. Investors also form their own opinion of BridgeBio Pharma's value that differs from its market value or its book value, called intrinsic value, which is BridgeBio Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BridgeBio Pharma's market value can be influenced by many factors that don't directly affect BridgeBio Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BridgeBio Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if BridgeBio Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BridgeBio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.